{
    "2020-09-04": [
        [
            {
                "time": "2023-10-01",
                "original_text": "AbbVie Partners With I-Mab for Cancer Drug",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "I-Mab",
                        "Cancer",
                        "Partners"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "AbbVie Inks $2.9 Billion Cancer Deal With Chinaâ€™s I-Mab",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "I-Mab",
                        "Cancer",
                        "Deal",
                        "$2.9 Billion"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "A Look Into AbbVie's Debt",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Debt"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "AbbVie Partners With I-Mab for Cancer Treatment Candidate",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "I-Mab",
                        "Cancer",
                        "Treatment"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "I-Mab's stock soars after AbbVie collaboration, which could be worth nearly $2 billion",
                "features": {
                    "keywords": [
                        "I-Mab",
                        "stock",
                        "soars",
                        "AbbVie",
                        "collaboration",
                        "$2 billion"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "The Daily Biotech Pulse: AbbVie In-licenses I-Mab's Cancer Drug, Savara Pulls The Plug On Cystic Fibrosis Study",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "I-Mab",
                        "Cancer",
                        "Drug",
                        "Savara",
                        "Cystic Fibrosis"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Like Dividends? I Bet You'll Love These 2 Stocks",
                "features": {
                    "keywords": [
                        "Dividends",
                        "Stocks"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "AbbVie and I-Mab Enter Into Global Strategic Partnership for Differentiated Immuno-oncology Therapy",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "I-Mab",
                        "Global",
                        "Strategic",
                        "Partnership",
                        "Immuno-oncology"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}